Presentation Information
[Pj-013-1]Low doses of L-DOPA/D2 antagonist therapy for idiopathic dystonia
Shinichi Matsumoto1, Hidetaka Koizumi1, Hideki Shimazu2, Satoshi Goto3 (1.Department of Neurology, Osaka Neurological Institute, Japan, 2.Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Japan, 3.Research Organization of Science and Technology, Ritsumeikan University, Japan)